Search for: "WYETH PHARMACEUTICALS COMPANY"
Results 461 - 480
of 547
Sort by Relevance
|
Sort by Date
18 Jul 2008, 8:34 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
10 Jul 2008, 6:11 pm
As plaintiffs' attorneys and defense attorneys representing pharmaceutical manufacturers await the filing of the respondent-plaintiff's merit brief in Wyeth v. [read post]
7 Jul 2008, 10:59 am
Two recent decisions illustrate just how difficult Canada is becoming as a jurisdiction for class actions defendants, particularly companies in the pharmaceutical industry. [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog) Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
18 Jun 2008, 3:03 pm
Large pharmaceutical companies have been waging war against inexpensive generic drugs for years at the national level. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real story:… [read post]
11 Jun 2008, 7:50 pm
Rost wrote: "Drug companies are their own worst enemies. [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
2 Jun 2008, 11:56 am
Moreover, on January 18th the Court had already agreed to hear another drug case, one involving a drug produced by Wyeth called Phenergan. [read post]
1 Jun 2008, 9:05 pm
The Federal Trade Commission announced the release of its FY 2007 Summary of Pharmaceutical Company Settlement Agreements. [read post]
23 May 2008, 1:03 am
– Discussion of Catherine Tremblay’s article on cost approach: (IP finance), US Congress cites free expression as reason ICANN must remain controlled by US government: (IP Justice), A new organisation around IP in your company? [read post]
15 May 2008, 12:41 pm
Riegel does not bar his lawsuit but the Supreme Court will consider this Fall whether to extend the preemption umbrella to pharmaceutical drugs in Wyeth v. [read post]
15 May 2008, 12:41 pm
Riegel does not bar his lawsuit but the Supreme Court will consider this Fall whether to extend the preemption umbrella to pharmaceutical drugs in Wyeth v. [read post]
15 May 2008, 12:04 am
And when the Food And Drug Administration reviewed the ad copy that included the tagline, "The change you deserve," it took issue with Wyeth Pharmaceuticals, which manufactures Effexor, saying that the company made "unsubstantiated superiority claims. [read post]
12 May 2008, 2:46 pm
For reasons I have written about previously, I believe that patients should not be pre-empted, or prohibited, from filing lawsuits against medical device and pharmaceutical companies. [read post]
12 May 2008, 12:30 pm
They are looking to extend their streak by asking the Supreme Court to extend the preemption umbrella to pharmaceutical drugs in Wyeth v. [read post]
12 May 2008, 12:30 pm
They are looking to extend their streak by asking the Supreme Court to extend the preemption umbrella to pharmaceutical drugs in Wyeth v. [read post]
1 May 2008, 11:21 am
One of the ways we feed this blog is doing what comes naturally to us lawyers - reading recent cases - and hoping that something inspires us. [read post]
